India has some genuinely strong oncology medicine manufacturers, but they’re not all built the same. Here’s what actually matters when you’re trying to find a credible partner in cancer drug manufacturing.
India’s CDMO sector is growing fast, and for good reason. But not every partner is built the same. Here’s a practical, no-jargon guide to understanding what CDMO companies in India actually offer and how to choose wisely.
CDMO stands for Contract Development and Manufacturing Organization. But knowing the full form is just the starting point. Here’s what CDMOs actually do, why they matter in pharma, and how they’re different from CMOs and CROs.
OEB Level-5 is the highest occupational safety classification in pharmaceutical manufacturing. It is required for cytotoxic oncology APIs and HPAPI compounds where airborne worker exposure must stay below 1 microgram per cubic metre of air. A genuinely certified facility needs ...
For most pharma companies, a CDMO partnership is significantly cheaper than building in-house. An in-house oncology manufacturing facility costs USD 150M–500M+ to build, takes 3–5 years to reach the first commercial batch, and carries full utilisation risk on your balance ...
To select the right oncology CDMO, evaluate seven criteria in this order: regulatory approvals (USFDA, MHRA, EU-GMP, ANVISA), OEB Level-5 containment certification, end-to-end oncology services, technology transfer track record, manufacturing capacity, BIOSECURE Act supply chain compliance, and quality culture. Always ...
There is a question every pharma company building an oncology pipeline eventually has to answer honestly: do we build this manufacturing capability ourselves, or do we find someone who already has it? Building it yourself means years of facility construction, ...
Walk into a hospital pharmacy in Nairobi, São Paulo, or Warsaw and pick up a generic oncology drug. Odds are better than most people realize that it was made in India. Not because India got lucky in the pharmaceutical race, ...
There is a question that comes up on almost every procurement call in the pharmaceutical industry, particularly when a company is entering a new market or scaling an oncology program: are we looking for a CMO or a CDMO? The ...
Keeping the quality high and adhering to standards that are safe for patients isn't a goal but a responsibility in the pharmaceutical industry. As medicines and health supplements are used by millions of people every day, even the smallest error ...